Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06171659

FDG PET/MR Imaging of Peripheral Pain Generators

Sponsor: University of Wisconsin, Madison

View on ClinicalTrials.gov

Summary

The purpose of this research is to determine if a PET/MRI scan using FDG can accurately identify the source of chronic pain. Identifying the source of pain may help doctors treat chronic pain more effectively. Approximately 128 participants will be enrolled and can expect to be on study for up to 12 months.

Official title: FDG PET/MR Imaging of Peripheral Pain Generators in Persistent Post-Surgical Pain (PPSP)

Key Details

Gender

All

Age Range

18 Years - 85 Years

Study Type

OBSERVATIONAL

Enrollment

128

Start Date

2024-11-19

Completion Date

2027-06

Last Updated

2025-09-25

Healthy Volunteers

Yes

Interventions

DRUG

FDG radiotracer

Fludeoxyglucose F 18 Injection is a positron emitting radiopharmaceutical containing no-carrier added radioactive 2-deoxy-2-\[18F\]fluoro-D-g1ucose, which is used for diagnostic purposes in conjunction with Positron Emission Tomography (PET). It is administered by intravenous injection. Dosage planned 0.14 mCi/kg/patient.

DEVICE

PET/MRI

positron emission tomography and magnetic resonance imaging

DEVICE

PET/CT imaging

positron emission tomography and computed tomography imaging

Locations (1)

UW School of Medicine and Public Health

Madison, Wisconsin, United States